32 tracked 13F filers disclose a position in 2KZ0 as of the latest SEC 13F filings, a combined $23.6M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | SUVRETTA CAPITAL MANAGEMENT, LLC | $5.3M | 717K | —Held | Q1 2026 | |
| 2 | TANG CAPITAL MANAGEMENT LLC | $4.9M | 664K | —Held | Q1 2026 | |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | $2.2M | 291K | →First observed position No prior filed position | Q1 2026 | |
| 4 | Rangeley Capital, LLC | $1.8M | 243K | ▲+183% Added · +157K sh | Q1 2026 | |
| 5 | Affinity Asset Advisors, LLC | $1.7M | 229K | —Held | Q1 2026 | |
| 6 | RENAISSANCE TECHNOLOGIES LLC | $1.4M | 188K | ▲+44% Added · +57K sh | Q1 2026 | |
| 7 | MILLENNIUM MANAGEMENT LLC | $1.1M | 142K | ▲New +142K sh | Q1 2026 | |
| 8 | Ikarian Capital, LLC | $758K | 102K | —Held | Q1 2026 | |
| 9 | BlackRock, Inc. | $742K | 100K | ▲+1.4% Added · +1K sh | Q1 2026 | |
| 10 | ADAR1 Capital Management, LLC | $608K | 82K | ▼−30% Reduced · −36K sh | Q1 2026 | |
| 11 | Groupe la Francaise | $597K | 80K | ▲New +80K sh | Q1 2026 | |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | $453K | 61K | ▼−11% Reduced · −7K sh | Q1 2026 | |
| 13 | CITADEL ADVISORS LLC | $441K | 59K | ▲New +59K sh | Q1 2026 | |
| 14 | TORNO CAPITAL, LLC | $360K | 48K | ▲+142% Added · +28K sh | Q1 2026 | |
| 15 | VANGUARD FIDUCIARY TRUST CO | $306K | 41K | →First observed position No prior filed position | Q1 2026 | |
| 16 | DIMENSIONAL FUND ADVISORS LP | $225K | 30K | ▲+14% Added · +4K sh | Q1 2026 | |
| 17 | JANE STREET GROUP, LLC | $159K | 21K | ▲New +21K sh | Q1 2026 | |
| 18 | XTX Topco Ltd | $145K | 19K | ▲New +19K sh | Q1 2026 | |
| 19 | BOOTHBAY FUND MANAGEMENT, LLC | $120K | 16K | —Held | Q1 2026 | |
| 20 | NORTHERN TRUST CORP | $102K | 14K | —Held | Q1 2026 | |
| 21 | FMR LLC | $76K | 10K | ▲49× Added · +10K sh | Q1 2026 | |
| 22 | WELLS FARGO & COMPANY/MN | $43K | 6K | ▼−0.7% Reduced · −40 sh | Q1 2026 | |
| 23 | MORGAN STANLEY | $32K | 4K | ▼−25% Reduced · −1K sh | Q1 2026 | |
| 24 | NewEdge Advisors, LLC | $16K | 2K | ▲New +2K sh | Q1 2026 | |
| 25 | Vanguard Global Advisers, LLC | $13K | 2K | →First observed position No prior filed position | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 4 funds opened a new position in 2KZ0 and 3 added to an existing one, while 2 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| CENTESSA PHARMACEUTICALS-ADRCNTA | 10 funds | $120.4M |
| WAVE LIFE SCIENCES LTDWVE | 10 funds | $44.8M |
| UNITEDHEALTH GROUP INCUNH | 9 funds | $1.2B |
| BOSTON SCIENTIFIC CORPBSX | 9 funds | $763.1M |
| ELI LILLY & COLLY | 9 funds | $700.2M |
| INSMED INCINSM | 9 funds | $680.3M |
| TERNS PHARMACEUTICALS INC430 | 9 funds | $524.3M |
| DANAHER CORPDHR | 9 funds | $394.5M |
| IONIS PHARMACEUTICALS INCIONS | 9 funds | $207.2M |
| ERASCA INCERAS | 9 funds | $188.5M |
| LEGEND BIOTECH CORP-ADRLEGN | 9 funds | $170.5M |
| REVOLUTION MEDICINES INCRVMD | 9 funds | $159.1M |
Ranked by how many of 2KZ0's institutional holders also hold each name, a cross-fund conviction signal.
No open-market insider transactions on file yet. Grants, gifts, and exercises live on the full insider page.
No filings captured for this ticker in the live stream yet.
Connected entities for 2KZ0
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/2KZ0/capital-change-brief"
Use Arkolith's capital_change_brief for 2KZ0. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for 2KZ0. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.